Nexalis Therapeutics Limited (ASX:NX1)

Nexalis Therapeutics Revenue

In the year 2025, Nexalis Therapeutics had annual revenue of 761.96K AUD with 89.63% growth. Nexalis Therapeutics had revenue of 204.84K in the half year ending December 31, 2025, a decrease of -73.25%.

• Revenue: 761.96K
• Revenue Growth: +89.63%
• P/S Ratio: 7.97
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 6.07M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	761.96K	360.15K	89.63%
Dec 31, 2024	401.81K	-802.24K	-66.63%
Dec 31, 2023	1.20M	1.18M	4,755.02%
Dec 31, 2022	24.80K	-156.94K	-86.35%
Dec 31, 2021	181.74K	159.61K	721.35%